This past spring, the province committed to providing public coverage for advanced glucose monitors, including continuous glucose monitoring (CGM) and flash glucose monitoring (Flash GM) for people with T1D up to age 25. The commitment also included expanded coverage under the Manitoba Pediatric Insulin Pump Program by changing the eligible age limit from under 18 […]
JDRF Canada and Brain Canada partner to fund critical research on mental health and type 1 diabetes
JDRF Canada and Brain Canada are pleased to announce the JDRF Canada – Brain Canada Addressing Mental Health in Type 1 Diabetes Team Grants, a new funding opportunity for Canadian researchers that aims to address mental health concerns in people with type 1 diabetes (T1D). 2021 marks the 100th anniversary since the discovery of insulin in Canada. Insulin has […]
BC Announces Coverage for Dexcom CGM Effective Today
“JDRF is grateful for the leadership the BC government has shown in taking this step towards Access for All and moving to cover continuous glucose monitoring under BC Pharmacare,” said Dave Prowten, President and CEO of JDRF Canada. British Columbia announced today that it will begin covering Dexcom G6 continuous glucose monitoring (CGM) for those […]
Virtual fundraiser unveiled in support of type 1 diabetes research
NEWS RELEASE TORONTO, ON — June 3, 2021 – The Sun Life Walk to Cure Diabetes for JDRF is the largest fundraising event in Canada that rallies the type 1 diabetes (T1D) community to unite and raise funds for T1D research. This year’s Walk is a family-friendly, virtual, and interactive event that will bring together […]
Funding commitment helps remove barriers to life-saving technology for Canadians living with type 1 diabetes
TD Bank Group supports JDRF’s Access for All program through the TD Ready Commitment. May 26, 2021 – Each day, as many as 300,000 Canadians living with type 1 diabetes (T1D) will make up to 300 decisions about their care. A wrong decision could mean life or death. T1D is an autoimmune disease that occurs when the […]
Government of Canada invests $35M in research and a national framework for diabetes
JDRF Canada is grateful to the Government of Canada for its commitment to honouring the centenary of the discovery of insulin in the 2021 federal budget. The budget proposes an investment of $35M for research into type 1 diabetes, surveillance and prevention, and to work towards the development of a national framework for diabetes. Continued […]
Manitoba and Saskatchewan Announce Expanded Coverage for Diabetes Technology
Wednesday, April 7, 2021, Toronto, ON – “JDRF Canada applauds this week’s provincial government announcements out of Saskatchewan and Manitoba, which are expanding access to insulin pumps and continuous and flash glucose monitoring devices for those living with type 1 diabetes,” says Dave Prowten, president and CEO, JDRF Canada. In the budget announced Tuesday on April […]
B.C.’s Glucose Monitoring Health Technology Assessment ignores evolution in technology and evidence
Diabetes Canada is joined by JDRF Canada and Type 1 Together in expressing disappointment with the recommendations recently published by British Columbia’s Health Technology Assessment (HTA) Committee.
New Data on COVID-19 Outcomes in Children with T1D
Understanding how challenging and unpredictable the COVID-19 pandemic is, especially for those impacted by type 1 diabetes (T1D), JDRF Canada continues to ensure that you have the credible and reliable information you need to help you better navigate the various and complex issues that are constantly arising.
Canadians with Chronic Health Conditions Reluctant to Seek Care During Pandemic, Survey Finds
Almost four in ten Canadians (38%) surveyed, who have been clinically diagnosed with a chronic disease, say they are avoiding the health care system altogether during the pandemic.
JDRF Access For All Events Bring Together B.C.’s Type 1 Diabetes Community, Clinicians, and Elected Officials to Discuss Life-Changing Technologies
JDRF Canada is hosting a series of virtual community forums to address the need for access to affordable type 1 diabetes (T1D) technologies for the more than 300,000 Canadians living with the disease who are otherwise burdened with crushing out-of-pocket costs that can amount to up to $15,000 every year per person.
JDRF Canada Has a Plan of Attack to Defeat the Monster That Burdens 300,000 Canadians
JDRF Canada is launching the $100 Million Campaign to Accelerate, a bold and innovative fundraising effort that aims to accelerate type 1 diabetes research and move beyond insulin